Albin Jeanne

885 total citations
15 papers, 594 citations indexed

About

Albin Jeanne is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Albin Jeanne has authored 15 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Albin Jeanne's work include Phagocytosis and Immune Regulation (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Albin Jeanne is often cited by papers focused on Phagocytosis and Immune Regulation (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Albin Jeanne collaborates with scholars based in France, Luxembourg and Italy. Albin Jeanne's co-authors include Stéphane Dedieu, Laurent Martiny, Christophe Schneider, Émilie Sick, K. Takeda, Jérôme Devy, Camille Boulagnon‐Rombi, Marco Rossi, Rolf Bjerkvig and Francesco Falciani and has published in prestigious journals such as Nature Communications, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Albin Jeanne

15 papers receiving 593 citations

Peers

Albin Jeanne

IMMUN

ONCOL

Camille L. Duran United States

Elise Langenkamp Netherlands

Jyoti Srivastava United States

Irwan T. Makagiansar United States

Ludmila Szabova United States

Anne Vehlow Germany

Yue Qi China

Victoria L. Bridgeman United Kingdom

Yujiro Takegami Japan

Camille L. Duran United States

Albin Jeanne

347 ×1.2

133 ×0.6

IMMUN

167 ×0.9

169 ×1.5

ONCOL

124 ×1.3

Citations per year, relative to Albin Jeanne Albin Jeanne (= 1×) peers Camille L. Duran

Countries citing papers authored by Albin Jeanne

Since Specialization

Citations

This map shows the geographic impact of Albin Jeanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albin Jeanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albin Jeanne more than expected).

Fields of papers citing papers by Albin Jeanne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albin Jeanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albin Jeanne. The network helps show where Albin Jeanne may publish in the future.

Co-authorship network of co-authors of Albin Jeanne

This figure shows the co-authorship network connecting the top 25 collaborators of Albin Jeanne. A scholar is included among the top collaborators of Albin Jeanne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albin Jeanne. Albin Jeanne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Untereiner, Valérie, Ganesh D. Sockalingum, Christine Terryn, et al.. (2021). Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry. Cancers. 13(23). 5950–5950. 3 indexed citations

Jeanne, Albin, Catherine Moali, Caroline Fichel, et al.. (2021). Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity. Cancers. 13(19). 5019–5019. 18 indexed citations

Jeanne, Albin, Charlotte Kawecki, Alexandre Kauskot, et al.. (2020). Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent. Arteriosclerosis Thrombosis and Vascular Biology. 41(1). e1–e17. 12 indexed citations

Daubon, Thomas, Céline Léon, Kim Clarke, et al.. (2019). Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nature Communications. 10(1). 1146–1146. 135 indexed citations

Boulagnon‐Rombi, Camille, Christophe Schneider, Chloé Leandri, et al.. (2018). LRP1 expression in colon cancer predicts clinical outcome. Oncotarget. 9(10). 8849–8869. 28 indexed citations

Jeanne, Albin, Valérie Untereiner, Corinne Perreau, et al.. (2017). Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide. Scientific Reports. 7(1). 7700–7700. 27 indexed citations

Jeanne, Albin, Benoît Langlois, Marion David, et al.. (2017). Identification of LRP-1 as an endocytosis and recycling receptor for β1-integrin in thyroid cancer cells. Oncotarget. 8(45). 78614–78632. 23 indexed citations

Jeanne, Albin, Camille Boulagnon‐Rombi, Jérôme Devy, et al.. (2016). Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide. Clinical & Experimental Metastasis. 33(7). 637–649. 14 indexed citations

Jeanne, Albin, Laurent Martiny, & Stéphane Dedieu. (2016). Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma. Pediatric Research. 81(3). 480–488. 11 indexed citations

10.

Jeanne, Albin, Christophe Schneider, Laurent Martiny, & Stéphane Dedieu. (2015). Original insights on thrombospondin-1-related antireceptor strategies in cancer. Frontiers in Pharmacology. 6. 252–252. 79 indexed citations

11.

Jeanne, Albin, Émilie Sick, Jérôme Devy, et al.. (2015). Identification of TAX2 peptide as a new unpredicted anti-cancer agent. Oncotarget. 6(20). 17981–18000. 21 indexed citations

12.

Devy, Jérôme, Nicolas Etique, Albin Jeanne, et al.. (2014). Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities. PLoS ONE. 9(7). e103839–e103839. 36 indexed citations

13.

Jeanne, Albin, Jean‐Jacques Hélesbeux, Olivier Duval, et al.. (2014). Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent. Investigational New Drugs. 33(1). 75–85. 6 indexed citations

14.

Sick, Émilie, Albin Jeanne, Christophe Schneider, et al.. (2012). CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest. British Journal of Pharmacology. 167(7). 1415–1430. 140 indexed citations

15.

Langlois, Benoît, Jérôme Devy, Albin Jeanne, et al.. (2012). LRP-1–CD44, a New Cell Surface Complex Regulating Tumor Cell Adhesion. Molecular and Cellular Biology. 32(16). 3293–3307. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact